Ligand decorated biodegradable nanomedicine in the treatment of cancer

Cancer is one of the major global health problems, responsible for the second-highest number of deaths. The genetic and epigenetic changes in the oncogenes or tumor suppressor genes alter the regulatory pathways leading to its onset and progression. Conventional methods are used in appropriate combi...

Full description

Saved in:
Bibliographic Details
Published in:Pharmacological research 2021-05, Vol.167, p.105544-105544, Article 105544
Main Authors: Ahmad, Ejaj, Ali, Asgar, Fatima, Munazza Tamkeen, Nimisha, Apurva, Kumar, Arun, Sumi, Mamta P., Sattar, Real Sumayya Abdul, Mahajan, Bhawna, Saluja, Sundeep Singh
Format: Article
Language:English
Subjects:
Animals
Antineoplastic Agents - administration & dosage
Antineoplastic Agents - pharmacokinetics
Antineoplastic Agents - therapeutic use
Biodegradable nanocarriers
CD44
Drug Carriers - chemistry
Drug Delivery Systems - methods
Humans
Hyaluronic Acid
Ligands
Nanomedicine - methods
Nanostructures - chemistry
Neoplasms - drug therapy
Phospholipids
Transferrin
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cancer is one of the major global health problems, responsible for the second-highest number of deaths. The genetic and epigenetic changes in the oncogenes or tumor suppressor genes alter the regulatory pathways leading to its onset and progression. Conventional methods are used in appropriate combinations for the treatment. Surgery effectively treats localized tumors; however, it fails to treat metastatic tumors, leading to a spread in other organs, causing a high recurrence rate and death. Among the different strategies, the nanocarriers-based approach is highly sought for, but its nonspecific delivery can cause a profound side effect on healthy cells. Targeted nanomedicine has the advantage of targeting cancer cells specifically by interacting with the receptors overexpressed on their surface, overcoming its non-specificity to target healthy cells. Nanocarriers prepared from biodegradable and biocompatible materials are decorated with different ligands by encapsulating therapeutic or diagnostic agents or both to target cancer cells overexpressing the receptors. Scientists are now utilizing a theranostic approach to simultaneously evaluate nanocarrier bio-distribution and its effect on the treatment regime. Herein, we have summarized the recent 5-year efforts in the development of the ligands decorated biodegradable nanocarriers, as a targeted nanomedicine approach, which has been highly promising in the treatment of cancer. [Display omitted]
ISSN:1043-6618
1096-1186
DOI:10.1016/j.phrs.2021.105544